IDXX vs. PEN: IDEXX Laboratories vs. Penumbra Stock Comparison

Company Profile

IDEXX Laboratories (IDXX) and Penumbra (PEN) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while Penumbra (PEN) is defensive at 0.68 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

IDEXX Laboratories (IDXX) at 68.93% clears its industry range for ROE, a sharper capital-efficiency signal than Penumbra (PEN) at 10.67%, which is closer to a typical peer reading.

For every dollar of sales, both IDEXX Laboratories (IDXX) at 25.36% and Penumbra (PEN) at 10.06% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of Penumbra (PEN) at 12.37%, which runs around its industry’s norm.

Profitability Metrics

Growth

Both IDEXX Laboratories (IDXX) at 10.42% and Penumbra (PEN) at 17.50% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Penumbra (PEN) at 1,155.56% clears its industry range for EPS growth, a much stronger earnings trajectory than IDEXX Laboratories (IDXX) at 22.59%, which is closer to a typical peer reading.

Growth Metrics

Financial Strength

Penumbra (PEN) at 5.89 carries current ratio above its industry’s typical mid-range, while IDEXX Laboratories (IDXX) at 1.19 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.

Penumbra (PEN) at 0.13 keeps leverage in the lower industry quartile, while IDEXX Laboratories (IDXX) at 0.52 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Neither IDEXX Laboratories (IDXX) nor Penumbra (PEN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Neither IDEXX Laboratories (IDXX) nor Penumbra (PEN) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Dividend Metrics

Valuation

IDEXX Laboratories (IDXX) at 45.56 is near its industry’s usual P/E ratio, while Penumbra (PEN) at 80.41 sits in the richer quartile — PEN needs stronger growth or earnings quality to justify the premium.

Both look expensive on sales: Penumbra (PEN) at 8.06 sits in the upper P/S ratio quartile, and IDEXX Laboratories (IDXX) at 11.42 prices even higher, above its industry range.

Both look rich against book: Penumbra (PEN) at 7.95 sits in the upper P/B ratio quartile, and IDEXX Laboratories (IDXX) at 28.50 prices even higher, above its industry range.

Valuation Metrics